Analyse Pediatrix Medical Group, Inc. (MD) — Kairos Score 69/100

À propos de Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Informations clés

🕴️ Activité des initiés (90 jours)

3 transactions — 0 achats et 0 ventes déclarés par les dirigeants de Pediatrix Medical Group, Inc..

🏦 Hedge Funds

15 fonds institutionnels déclarent une position sur MD dans leur dernière déclaration trimestrielle SEC.

📰 Actualités récentes

15 articles récents sur MD.

• 3 Healthcare Stocks That Concern Us
• Can Pediatrix Sustain Growth Despite Lower Patient Volumes?

🧠 Ce qui fait Kairos Insider

Au-dela des donnees brutes, nous agregeons et scoring tout le signal smart money pour vous donner une vue unique.